How an unsolved medical mystery became a life-saving breakthrough

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

Trevi Therapeutics: Late-Stage Transition Meets Execution Risk

Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...
The Manila Times

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
Pulmonology Advisor

Isolated ANCA-Associated ILD Is an Emerging Fibrotic ILD Phenotype

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.
AHA/ASA Journals

Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
GEN - Genetic Engineering and Biotechnology News

StockWatch: IPO Market Shows Sign of Life with Avalyn Filing

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn ...